[1] Johansen JS, Williamson MK, Rice JS, et al.Identification of proteins secreted by human osteoblastic cells in culture[J].J Bone Miner Res, 1992,7(5):501-512.
[2] Kanazawa J, Kitazawa H, Masuko H, et al.A Cis-eQTL allele regulating reduced expression of CHI3L1 is associated with late-onset adult asthma in Japanese cohorts[J].BMC Med Genet, 2019,20(1):58.
[3] 王玲,贲素琴.YKL-40与呼吸系统疾病相关的研究进展[J].国际呼吸杂志,2020,40(5):390-394.
[4] 王兰,欧维琳.YKL-40在支气管哮喘发病中作用的研究进展[J].山东医药,2020,60(34):92-95.
[5] Cheng KC, Lee JJ, Wang SL, et al.Elevated plasma YKL-40 level is found in the dogs with cancer and is related to poor prognosis[J].J Vet Sci, 2019,20(5):e53.
[6] Mazur M, ZieliÑska A, Grzybowski MM, et al.Chitinases and chitinase-like proteins as therapeutic targets in inflammatory diseases, with a special focus on inflammatory bowel diseases[J].Int J Mol Sci, 2021,22(13):6966.
[7] Kumar A, Zhang KYJ.Human chitinases: structure, function, and inhibitor discovery[J].Adv Exp Med Biol, 2019,1142:221-251.
[8] 刘丽波,段旭峰,孔学哲,等.肝硬化患者血清YKL-40水平变化及临床意义[J].中国医药导报,2020,17(34):119-122.
[9] Hormigo A, Gu B, Karimi S, et al.YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas[J].Clin Cancer Res, 2006,12(19):5698-5704.
[10] Sun Y, Kong XF, Wu SF, et al.YKL-40 as a new biomarker of disease activity in Takayasu arteritis[J].Int J Cardiol, 2019,293:231-237.
[11] Kim EG, Kim MN, Hong JY, et al.Chitinase 3-like 1 contributes to food allergy via M2 macrophage polarization[J].Allergy Asthma Immunol Res, 2020,12(6):1012-1028.
[12] 杜敬佩,王园园,李赢,等.聚乙二醇干扰素α-2a联合替诺福韦酯对慢性乙型肝炎患者胶原代谢指标、YKL-40、MMP-2及MMP-9的影响[J].临床医学研究与实践,2020,5(34):80-82.
[13] Batista K, Eulate-Beramendi SA, Piñ AK, et al.Mesenchymal/proangiogenic factor YKL-40 related to glioblastomas and its relationship with the subventricular zone[J].Folia Neuropathol, 2017,55(1):14-22.
[14] Zhou Y, Meng LJ, Wang J.Changes in serum human cartilage glycoprotein-39 and high-mobility group box 1 in preterm infants with bronchopulmonary dysplasia[J].Zhongguo Dang Dai Er Ke Za Zhi, 2020,22(4):334-338.
[15] Ramos-Espinosa G, Wang YY, Brandner JM, et al.Melanoma associated chitinase 3-like 1 promoted endothelial cell activation and immune cell recruitment[J].Int J Mol Sci, 2021,22(8):3912.
[16] Ling H, Recklies AD.The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha[J].Biochem J, 2004,380(Pt 3):651-659.
[17] 田胜兰,王国延,杨扬.人甲壳质酶蛋白40通过PI3K/Akt信号通路调控膝骨性关节炎兔软骨细胞的凋亡[J].中国组织工程研究,2020,24(32):5108-5113.
[18] Spoorenberg SMC, Vestjens SMT, Rijkers GT, et al.YKL-40, CCL18 and SP-D predict mortality in patients hospitalized with community-acquired pneumonia[J].Respirology, 2017,22(3):542-550.
[19] Outinen TK, Mantulap, Jaatinen P, et al.Glycoprotein YKL-40 is elevated and predicts disease severity in puumala Hantavirus infection[J].Viruses, 2019,11(9):767.
[20] Sun Y, Shi ZQ, Liu B, et al.YKL-40 mediates airway remodeling in asthma via activating FAK and MAPK signaling pathway[J].Cell Cycle, 2020,19(11):1378-1390.
[21] Tong X, Wang DG, Liu ST, et al.The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review[J].Int J Chron Obstruct Pulmon Dis, 2018,13:409-418.
[22] Komi DEA, Kazemi T, Bussink AP.New insights into the relationship between chitinase-3-like-1 and asthma[J].Curr Allergy Asthma Rep, 2016,16(8):57.
[23] Henckel E, James A, Konradsen JR, et al.A novel association between YKL-40, a marker of structural lung disease, and short telomere length in 10-year-old children with bronchopulmonary dysplasia[J].Children (Basel), 2021,8(2):80.
[24] Yildiz H, Alp HH, Sünnetçioĝlu A, et al.Evaluation serum levels of YKL-40, Periostin, and some inflammatory cytokines together with IL-37, a new anti-inflammatory cytokine, in patients with stable and exacerbated asthma[J].Heart Lung, 2021,50(1):177-183.
[25] Wang J, Lv HJ, Luo Z, et al.Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD[J].Respir Res, 2018,19(1):47.
[26] Przysucha N, Górska K, Krenke R.Chitinases and chitinase-like proteins in obstructive lung diseases - current concepts and potential applications[J].Int J Chron Obstruct Pulmon Dis, 2020,15:885-899.
[27] Yildiz H, Alp HH, Sünnetçioĝlu A, et al.Evaluation serum levels of YKL-40, Periostin, and some inflammatory cytokines together with IL-37, a new anti-inflammatory cytokine, in patients with stable and exacerbated asthma[J].Heart Lung, 2021,50(1):177-183.
[28] 柳林,崔昕燕,薛华军,等.儿童和成人变应性鼻炎患者血清YKL-40检测及初步探讨[J].中国中西医结合耳鼻咽喉科杂志,2018,26(3):211-213.
[29] Park SJ, Jun YJ, Kim TH, et al.Increased expression of YKL-40 in mild and moderate/severe persistent allergic rhinitis and its possible contribution to remodeling of nasal mucosa[J].Am J Rhinol Allergy, 2013,27(5):372-380.
[30] 皮力东·库亚西,雍军.变应性鼻炎患者血清中YKL-40含量与嗜酸性粒细胞功能、Th1/Th2型及Treg/Th17型免疫的相关性[J].海南医学院学报,2017,23(20):2873-2876.
[31] 杨茂森,于君萍,陈大明.辛芩颗粒与氯雷他定联合用药对变应性鼻炎患者IFN-γ、IL-4、血清甲壳质酶蛋白-40的影响[J].大连医科大学学报,2018,40(5):441-444.
[32] 张晓娟,项红霞,郁志伟,等.毛细支气管炎患儿血清人软骨糖蛋白及潮气呼吸肺功能改变[J].南京医科大学学报(自然科学版),2016,36(1):69-72.
[33] Yang XG, Sheng GY.YKL-40 levels are associated with disease severity and prognosis of viral pneumonia, but not available in bacterial pneumonia in children[J].BMC Pediatr, 2018,18(1):381.
[34] 杨兴鸽.人软骨糖蛋白39(YKL-40)与儿童病毒感染性肺炎的关系研究[D].郑州:郑州大学,2018.
[35] 方晓丹,王爱珍,王有成.儿童难治性肺炎支原体肺炎危险因素分析[J].中国妇幼保健,2021,36(6):1368-1370.
[36] 任彦红,陈丹,张广超,等.血清25羟维生素D、YKL-40检测在诊治儿童难治性支原体肺炎中的临床意义[J].医学研究杂志,2019,48(2):121-126.
[37] Huang LL, Li RH, Li J, et al.Association of YKL-40 in bronchoalveolar lavage fluid with airway damage in children with Mycoplasma pneumoniae pneumonia[J].Zhongguo Dang Dai Er Ke Za Zhi, 2019,21(12):1188-1192.
[38] James AJ, Nordlund B, Konradsen JR, et al.YKL-40 is a proposed biomarker of inflammation and remodelling elevated in children with bronchopulmonary dysplasia compared to asthma[J].Acta Paediatr, 2021,110(2):641-642.
